RESEARCH NEWS 2011-07-29 Research News Human beings stand out from other species by having big brains, complex cognitive abilities, and long lifespans. Two new papers suggest we may pay for these blessings with increased vulnerability to age-related cognitive declines. Both studi
CONFERENCE COVERAGE 2011-07-29 Conference Coverage After disappointing trial results for Alzheimer’s disease (AD) drugs, all eyes are on the Phase 3 clinical trials of two monoclonal antibodies to amyloid-β: bapineuzumab, developed by Janssen Alzheimer Immunotherapy and Pfizer, and sol
PAPER Vercambre MN, Grodstein F, Manson JE, Stampfer MJ, Kang JH
Arch Intern Med. 2011 Jul 25;171(14):1244-50. PubMed: 21771894
PAPER Middleton LE, Manini TM, Simonsick EM, Harris TB, Barnes DE, Tylavsky F, Brach JS, Everhart JE, Yaffe K
Arch Intern Med. 2011 Jul 25;171(14):1251-7. PubMed: 21771893
CONFERENCE COVERAGE SERIES Paris: Renamed ARIA, Vasogenic Edema Common to Anti-Amyloid Therapy Paris: Semagacestat Autopsy and Other News of Trial Tribulations Paris: More Trial News, Mixed at Best Paris: President and All, French Science Takes the Stage Paris: Beyond Genomics, Fre